Two Sigma Investments’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
KWM
FCBT
Two Sigma Investments's XPH Position: Q1 2026 in Review
Two Sigma Investments increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 290% in Q1 2026, buying an estimated $2.1M and bringing the position to 50,700 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2510.
Two Sigma Investments first reported a position in XPH in Q2 2024 and has held it in 3 quarters since. 82 funds tracked by Wall St. Rank hold XPH as of Q1 2026.
- Two Sigma Investments held 50,700 shares of State Street SPDR S&P Pharmaceuticals ETF worth $2.74M as of Q1 2026.
- Two Sigma Investments bought 37,700 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2026, an estimated $2.1M.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2510 holding.
- Two Sigma Investments first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2024 and has held it in 3 quarters since.
- 82 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.